Search clinical trials for: Dopamine Transporter

Total 5999 results

Shanghai Mental Health Center
Yantai University

Recruiting

Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Major Depressive Disorder

China
Centre Hospitalier Universitaire de Liege
Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators

Recruiting

Baby Detect : Genomic Newborn Screening

Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions

Belgium
GE Healthcare
Fortrea, Inc.

Recruiting

Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

Parkinson Disease | Movement Disorders

United States
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Recruiting

Correlation Between COMT Val158Met Polymorphism and Dopaminergic Transporter Density (DAT) in Obese Women

Obesity

Brazil
St. Joseph's Hospital and Medical Center, Phoenix

Not yet recruiting

Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD)

Post-traumatic Stress Disorder
Pfizer

Completed

Voxelotor CYP and Transporter Cocktail Interaction Study

Sickle Cell Disease

United States
Shanghai Mental Health Center
Yantai University

Completed

Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Major Depressive Disorder

China
Turku University Hospital
Helsinki University Central Hospital

Active, not recruiting

Non-motor Symptoms and Brain Dopamine Transporter Binding (NMDAT)

Parkinson Disease | Parkinsonism
Julie Gurwell

Completed

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

Parkinson Disease

United States
Pusan National University Hospital

Completed

Role of Dopamine Transporter in Glucose Control

Obesity

Korea, Republic of
National Institute of Mental Health (NIMH)

Completed

Imaging and Genetic Investigation of Learning and Decision Making

Polymorphism- Genetic | Reward Mediating System

United States
National Cheng-Kung University Hospital

Terminated

The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease (Parkinson's)

Depression | Parkinson Disease
University of Erlangen-Nürnberg Medical School
AstraZeneca

Completed

Quetiapine and the Dopaminergic Epigenetic Control

Schizophrenia

Germany
University Hospital, Toulouse

Completed

Dopaminergic Loss and Pain in Parkinson's Disease

Pain | Parkinson's Disease

France
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression

Depression

United States
National Institute on Drug Abuse (NIDA)

Completed

Stem Cell Study of Genetics and Drug Addiction

Induced Pluripotent Stem Cells

United States
Institute for Neurodegenerative Disorders
National Institutes of Health (NIH); Molecular NeuroImaging

Completed

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

Parkinson's Disease | Parkinsonian Syndrome
Mclean Hospital

Completed

Depression and Dopamine Transporter Function Study Using C-11 Altropane

Anhedonia | Major Depressive Disorder

United States
Pusan National University Hospital

Completed

Prediction of Future Weight Change With Dopamine Transporter

Weight Change, Body
University Hospital, Tours

Terminated

Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999 (LBT 999)

Idiopathic Parkinson Disease

France
Molecular NeuroImaging
Institute for Neurodegenerative Disorders

Completed

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

Parkinson Disease

United States
Rambam Health Care Campus

Completed

Apomorphine Effects on Experimental Pain

Healthy

Israel
Assistance Publique - Hôpitaux de Paris
Association Française contre les Myopathies (AFM), Paris; ARS (Association... and other collaborators

Completed

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls (DOSERAL)

Amyotrophic Lateral Sclerosis

France
Academisch Medisch Centrum - Universiteit van Amsterdam...
Alkermes, Inc.; ZonMw: The Netherlands Organisation for Health Research and...

Completed

Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT (XRNT)

Opioid-Related Disorders | Heroin Dependence

Netherlands
Boehringer Ingelheim

Completed

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Heart Failure
University Hospital, Bordeaux

Completed

Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies (IBVM/DATSCAN)

Dementia With Lewy Bodies

France
Institute for Neurodegenerative Disorders
United States Department of Defense

Completed

Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression (ELLDOPA)

Parkinson Disease
Sunovion

Completed

A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects

Healthy

United States
Massachusetts General Hospital

Completed

Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate

Drug Binding to DAT Receptors

United States
University Hospital, Lille

Completed

Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II) (PARKGAIT-II)

Parkinson's Disease | Dementia | Gait Disorders, Neurologic

France
Hallym University Medical Center

Completed

Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) (NETADHD)

Pharmacogenetics | Attention Deficit Disorder With Hyperactivity | Methylphenidate

Korea, Republic of
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

Healthy Volunteers

United States
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults

Healthy Volunteers

United States
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD

Attention Deficit Hyperactivity Disorder
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Associação Fundo de Incentivo...

Completed

Dopamine Transporter Density Profiles in Patients With Periodic Limb Movements (DOPATRANSPLM)

Periodic Limb Movements in Sleep

Brazil
Institute for Neurodegenerative Disorders
United States Department of Defense; Boehringer Ingelheim

Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Parkinson Disease | Parkinsonian Syndrome

United States
Institute for Neurodegenerative Disorders
GE Healthcare; Pfizer

Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Parkinson Disease | Parkinsonian Syndrome

Spain, Austria, Germany, Italy
National Institute of Mental Health (NIMH)

Completed

Use of [18F]FECNT in Positron Emission Tomography

Healthy

United States
National Institute of Mental Health (NIMH)

Completed

Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects

Healthy | Mood Disorder

United States
GE Healthcare

Completed

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

Vascular Dementia | Lewy Body Dementia | Alzheimer's | Non-DLB Dementia

Germany
Hospital de Clinicas de Porto Alegre
Vifor Pharma

Not yet recruiting

IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency (COMBINED-HF)

Heart Failure, Systolic | Iron Deficiencies

Brazil
Massachusetts General Hospital
Patient-Centered Outcomes Research Institute

Not yet recruiting

Sequential Multiple Assignment Randomized Trial for Bipolar Depression (SMART-BD)

Depression | Bipolar I Disorder

United States, Canada
University of Dundee
Juvenile Diabetes Research Foundation; Lexicon Pharmaceuticals

Not yet recruiting

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes (SOPHIST)

Heart Failure | Type 1 Diabetes
Cantonal Hospital Graubuenden
University of Zurich

Not yet recruiting

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease (SIDIA)

Autosomal Dominant Polycystic Kidney Disease

Switzerland
Beijing Anzhen Hospital

Not yet recruiting

Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation (DARE-AF)

Atrial Fibrillation

China
Yi Han
Qianfoshan Hospital

Recruiting

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Renal Insufficiency | Gene Polymorphism | Edoxaban

China
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy (SOTA-CROSS HCM)

Hypertrophic Cardiomyopathy Without Obstruction
Erzincan Military Hospital

Not yet recruiting

Evaluating the Efficacy and Safety of Preoperative Administration of Duloxetine for Pain Management in Women Undergoing Vaginal Hysterectomy.

Postoperative Pain | Vaginal Hysterectomy
Ironshore Pharmaceuticals and Development, Inc

Not yet recruiting

Ph3 Multicenter, 3wk RDBPC Efficacy, Safety & PK Study of Evening Dosed MPH HCl ER Capsules (HLD200) in Children 4-5 Yr With ADHD

Attention Deficit Hyperactivity Disorder
Ann & Robert H Lurie Children's Hospital of Chicago
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Not yet recruiting

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease (SGLT2I-IN-KIDS)

Chronic Kidney Diseases | Pediatric Kidney Disease

United States

Search clinical trials for: Dopamine Transporter

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations